Memorial Sloan Kettering Cancer Center
Stage IV NSCLC 2020 Update: Is There a Benefit to Short-Course Chemotherapy and IO Combination in Disease Without an Oncogenic Driver?
By
Nebraska Oncology Society
FEATURING
Gregory Riely
By
Nebraska Oncology Society
FEATURING
Gregory Riely
Login to view comments.
Click here to Login